Pacific Edge Limited (PEB.AX)
AUD 0.11
(-4.35%)
AUD 0.11
(-4.35%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -33.59 Million NZD | 2.37% |
| 2023 | -34.41 Million NZD | -55.12% |
| 2022 | -22.18 Million NZD | 1.68% |
| 2021 | -22.56 Million NZD | -13.76% |
| 2020 | -19.83 Million NZD | -3.2% |
| 2019 | -19.22 Million NZD | 11.63% |
| 2018 | -21.75 Million NZD | 3.13% |
| 2017 | -22.45 Million NZD | -25.48% |
| 2016 | -17.89 Million NZD | -38.06% |
| 2015 | -12.96 Million NZD | -26.25% |
| 2014 | -10.26 Million NZD | -48.48% |
| 2013 | -6.91 Million NZD | -52.69% |
| 2012 | -4.52 Million NZD | -35.33% |
| 2011 | -3.34 Million NZD | 3.18% |
| 2010 | -3.45 Million NZD | -15.9% |
| 2009 | -2.98 Million NZD | -55.64% |
| 2008 | -1.91 Million NZD | -2.2% |
| 2007 | -1.87 Million NZD | 24.87% |
| 2006 | -2.49 Million NZD | 14.92% |
| 2005 | -2.93 Million NZD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q4 | -7.86 Million NZD | 0.0% |
| 2024 Q1 | -8.93 Million NZD | -2.98% |
| 2024 Q2 | -8.93 Million NZD | 0.0% |
| 2024 Q3 | -7.86 Million NZD | 12.07% |
| 2024 FY | -33.59 Million NZD | 2.37% |
| 2023 Q4 | -8.68 Million NZD | 0.0% |
| 2023 FY | -34.41 Million NZD | -55.12% |
| 2023 Q3 | -8.68 Million NZD | -18.13% |
| 2023 Q2 | -7.34 Million NZD | 0.0% |
| 2023 Q1 | -7.34 Million NZD | -34.33% |
| 2022 Q2 | -4.79 Million NZD | 0.0% |
| 2022 Q3 | -5.47 Million NZD | -14.08% |
| 2022 Q4 | -5.47 Million NZD | 0.0% |
| 2022 FY | -22.18 Million NZD | 1.68% |
| 2022 Q1 | -4.79 Million NZD | -18.18% |
| 2021 Q2 | -3.78 Million NZD | 0.0% |
| 2021 Q1 | -3.78 Million NZD | 21.31% |
| 2021 Q4 | -4.05 Million NZD | 0.0% |
| 2021 FY | -22.56 Million NZD | -13.76% |
| 2021 Q3 | -4.05 Million NZD | -7.17% |
| 2020 Q3 | -4.81 Million NZD | -1.04% |
| 2020 FY | -19.83 Million NZD | -3.2% |
| 2020 Q4 | -4.81 Million NZD | 0.0% |
| 2020 Q2 | -4.76 Million NZD | 0.0% |
| 2020 Q1 | -4.76 Million NZD | -1.87% |
| 2019 Q3 | -4.67 Million NZD | -5.23% |
| 2019 FY | -19.22 Million NZD | 11.63% |
| 2019 Q1 | -4.44 Million NZD | 10.05% |
| 2019 Q4 | -4.67 Million NZD | 0.0% |
| 2019 Q2 | -4.44 Million NZD | 0.0% |
| 2018 Q1 | -5.06 Million NZD | 10.59% |
| 2018 FY | -21.75 Million NZD | 3.13% |
| 2018 Q4 | -4.93 Million NZD | 0.0% |
| 2018 Q2 | -5.06 Million NZD | 0.0% |
| 2018 Q3 | -4.93 Million NZD | 2.49% |
| 2017 Q3 | -5.66 Million NZD | -30.19% |
| 2017 Q4 | -5.66 Million NZD | 0.0% |
| 2017 FY | -22.45 Million NZD | -25.48% |
| 2017 Q2 | -4.35 Million NZD | 0.0% |
| 2017 Q1 | -4.35 Million NZD | 5.02% |
| 2016 FY | -17.89 Million NZD | -38.06% |
| 2016 Q4 | -4.58 Million NZD | 0.0% |
| 2016 Q1 | -3.66 Million NZD | 9.47% |
| 2016 Q2 | -3.66 Million NZD | 0.0% |
| 2016 Q3 | -4.58 Million NZD | -24.98% |
| 2015 Q4 | -4.04 Million NZD | 0.0% |
| 2015 FY | -12.96 Million NZD | -26.25% |
| 2015 Q3 | -4.04 Million NZD | -56.8% |
| 2015 Q2 | -2.58 Million NZD | 0.0% |
| 2015 Q1 | -2.58 Million NZD | -12.97% |
| 2014 Q2 | -2.52 Million NZD | 0.0% |
| 2014 Q1 | -2.52 Million NZD | -94.5% |
| 2014 FY | -10.26 Million NZD | -48.48% |
| 2014 Q4 | -2.28 Million NZD | 0.0% |
| 2014 Q3 | -2.28 Million NZD | 9.43% |
| 2013 Q3 | -1.29 Million NZD | 0.0% |
| 2013 Q4 | -1.29 Million NZD | 0.0% |
| 2013 FY | -6.91 Million NZD | -52.69% |
| 2012 FY | -4.52 Million NZD | -35.33% |
| 2011 FY | -3.34 Million NZD | 3.18% |
| 2010 FY | -3.45 Million NZD | -15.9% |
| 2009 FY | -2.98 Million NZD | -55.64% |
| 2008 FY | -1.91 Million NZD | -2.2% |
| 2007 FY | -1.87 Million NZD | 24.87% |
| 2006 FY | -2.49 Million NZD | 14.92% |
| 2005 FY | -2.93 Million NZD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Australian Clinical Labs Limited | 56.9 Million AUD | 159.044% |
| BCAL Diagnostics Limited | -5.44 Million AUD | -516.814% |
| Genetic Signatures Limited | -22.33 Million AUD | -50.446% |
| Genetic Technologies Limited | -6.53 Million AUD | -413.969% |
| Healius Limited | 39.7 Million AUD | 184.632% |
| Imagion Biosystems Limited | -15.81 Million AUD | -112.46% |
| Integral Diagnostics Limited | 5.36 Million AUD | 726.029% |
| INOVIQ Ltd | -9.51 Million AUD | -253.282% |
| Microba Life Sciences Limited | -26.84 Million AUD | -25.169% |
| Monash IVF Group Limited | -5.34 Million AUD | -528.724% |
| Rhythm Biosciences Limited | -6.7 Million AUD | -400.936% |
| Sonic Healthcare Limited | 816.45 Million AUD | 104.115% |